Company: PFSA
Filing Date: 2025-08-25
Form Type: 424B3
Source: 0001213900-25-080387
Chunk: 1

Company: Profusa, Inc.
Filing Date: 2025-08-25
Form: 424B3
Chunk 1
---
 aggregate gross proceeds under the Purchase Agreement from sales of Common Stock we may elect to make to put to Ascent pursuant to the Purchase Agreement after the date of this prospectus. See “The Committed Equity Facility” for a description of the Purchase Agreement and “ Selling Stockholder ” for additional information regarding Ascent. Ascent may sell or otherwise dispose of ELOC Shares described in this prospectus in a number of different ways and at varying prices. See “Plan of Distribution — Offer and Resale of Common Stock by the Selling Stockholder” for more information about how Ascent may sell or otherwise dispose of ELOC Shares pursuant to this prospectus. Ascent is deemed to be an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended, or the Securities Act. The Selling Stockholder may sell the shares of our common stock offered by this prospectus from time to time on terms to be determined at the time of sale through ordinary brokerage transactions or through any other means described in this prospectus under the caption “Plan of Distribution.” The shares of common stock may be sold at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing market price or at negotiated prices. We will pay the expenses incurred in registering under the Securities Act the offer and sale of the shares of Common Stock to which this prospectus relates by the Selling Stockholder, including legal and accounting fees. See “Plan of Distribution — Offer and Resale of Common Stock by the Selling Stockholder” beginning on page 149. Our common stock is listed on the Nasdaq Global Market under the symbol “PFSA.” On August 5, 2025, the last sale price for our common stock as reported on the Nasdaq Global Market was $0.53 per share. We are a “smaller reporting company” as defined under the federal securities laws and, as such, have elected to comply with certain reduced public company reporting requirements for this prospectus and may elect to do so in future filings. Investing in our securities involves a high degree of risk. See the section entitled “ Risk Factors ” appearing on page 6 of this prospectus for a discussion of information that should be considered in connection with an investment in our securities. Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense. The date of this prospect